Englisch

This sample attributes data table includes body site where sample was collected, analyte type, genotyping and sequencing centers, and sample collection date.

9 Formulare  
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. This subject consent data table contains subject IDs, consent group information, subject aliases, and affection status (all subjects are controls).
    3. This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes the study/substudy (phs accession) that the sample belongs to and sample use.
    4. This subject phenotype data table includes subject sex, race, age, year of enrollment, log2 antibody titers (n=18 variables; Assays: hemagglutination inhibition and neutralization; Antigens: H1N1, H3N2, FluB; Time: preimmune, 14 days, and 28 days).
    5. This sample attributes data table includes body site where sample was collected, analyte type, and genotyping center.
    6. This sample GEO mapping data table includes a mapping of sample IDs to GEO accession IDs, and RNA IDs collected at each study visit.
    7. This subject phenotype data table includes subject sex, age, year of enrollment, receipt of seasonal influenza vaccine (n=3; 2008-2010), recipet of 2009 pH1N1 swine influenza vaccine, virus detected in nasal wash, antiviral drug taken by subjects, maximum oral temperature on first day of illness, duration of symptoms, and log2 antibody titers (n=4 variables; hemagglutination inhibition assay; Time: baseline, acute infection, convalescent, and spring).
    8. This sample attributes data table includes body site where sample was collected, analyte type, genotyping and sequencing centers, and sample collection date.
    9. This subject GEO mapping data table includes a mapping of subject IDs to GEO accession IDs, and RNA IDs collected different time points.
pht005096
Beschreibung

pht005096

Alias
UMLS CUI [1,1]
C3846158
De-identified Sample ID
Beschreibung

SAMPLE_ID

Datentyp

string

Alias
UMLS CUI [1,1]
C4684638
UMLS CUI [1,2]
C1299222
Body site where sample was collected
Beschreibung

BODY_SITE

Datentyp

string

Alias
UMLS CUI [1,1]
C0449705
Analyte Type
Beschreibung

ANALYTE_TYPE

Datentyp

string

Alias
UMLS CUI [1,1]
C4744818
Name of the center which conducted genotyping
Beschreibung

GENOTYPING_CENTER

Datentyp

string

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C5575037
UMLS CUI [1,3]
C1285573
Name of the center which conducted sequencing
Beschreibung

SEQUENCING_CENTER

Datentyp

string

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C5575037
UMLS CUI [1,3]
C1561491
Sample collection date
Beschreibung

COMMENT

Datentyp

string

Alias
UMLS CUI [1,1]
C1302413
Zum Seitenanfang zurückkehren

Ähnliche Modelle

This sample attributes data table includes body site where sample was collected, analyte type, genotyping and sequencing centers, and sample collection date.

9 Formulare
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. This subject consent data table contains subject IDs, consent group information, subject aliases, and affection status (all subjects are controls).
    3. This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes the study/substudy (phs accession) that the sample belongs to and sample use.
    4. This subject phenotype data table includes subject sex, race, age, year of enrollment, log2 antibody titers (n=18 variables; Assays: hemagglutination inhibition and neutralization; Antigens: H1N1, H3N2, FluB; Time: preimmune, 14 days, and 28 days).
    5. This sample attributes data table includes body site where sample was collected, analyte type, and genotyping center.
    6. This sample GEO mapping data table includes a mapping of sample IDs to GEO accession IDs, and RNA IDs collected at each study visit.
    7. This subject phenotype data table includes subject sex, age, year of enrollment, receipt of seasonal influenza vaccine (n=3; 2008-2010), recipet of 2009 pH1N1 swine influenza vaccine, virus detected in nasal wash, antiviral drug taken by subjects, maximum oral temperature on first day of illness, duration of symptoms, and log2 antibody titers (n=4 variables; hemagglutination inhibition assay; Time: baseline, acute infection, convalescent, and spring).
    8. This sample attributes data table includes body site where sample was collected, analyte type, genotyping and sequencing centers, and sample collection date.
    9. This subject GEO mapping data table includes a mapping of subject IDs to GEO accession IDs, and RNA IDs collected different time points.
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
pht005096
C3846158 (UMLS CUI [1,1])
SAMPLE_ID
Item
De-identified Sample ID
string
C4684638 (UMLS CUI [1,1])
C1299222 (UMLS CUI [1,2])
BODY_SITE
Item
Body site where sample was collected
string
C0449705 (UMLS CUI [1,1])
ANALYTE_TYPE
Item
Analyte Type
string
C4744818 (UMLS CUI [1,1])
GENOTYPING_CENTER
Item
Name of the center which conducted genotyping
string
C1301943 (UMLS CUI [1,1])
C5575037 (UMLS CUI [1,2])
C1285573 (UMLS CUI [1,3])
SEQUENCING_CENTER
Item
Name of the center which conducted sequencing
string
C1301943 (UMLS CUI [1,1])
C5575037 (UMLS CUI [1,2])
C1561491 (UMLS CUI [1,3])
COMMENT
Item
Sample collection date
string
C1302413 (UMLS CUI [1,1])
Zum Seitenanfang zurückkehren